Table 2.
Retinopathy, Present versus Absent |
Model 1 (HR and 95% CI) |
Model 2 (HR and 95% CI) |
Model 3 (HR and 95% CI) |
Model 4 (HR and 95% CI) |
---|---|---|---|---|
All-Cause Mortality | ||||
All Participants | 1.26 (1.10, 1.43)** | 1.20 (1.05, 1.37)** | 1.16 (1.01, 1.35)* | 1.12 (0.97, 1.30) |
Men | 1.33 (1.11, 1.60)** | 1.30 (1.08, 1.57)** | 1.30 (1.06, 1.60)* | 1.28 (1.04, 1.57)* |
Women | 1.19 (0.98, 1.44) | 1.13 (0.93, 1.38) | 1.04 (0.84, 1.30) | 0.98 (0.78, 1.22) |
Cardiovascular-Disease Related Mortality |
||||
All Participants | 1.57 (1.20, 2.06)** | 1.46 (1.11, 1.93)** | 1.42 (1.05, 1.93)* | 1.24 (0.91, 1.69) |
Men | 1.81 (1.25, 2.63)** | 1.72 (1.18, 2.50)** | 1.81 (1.19, 2.73)** | 1.74 (1.14, 2.66)** |
Women | 1.37 (0.92, 2.07) | 1.31 (0.87, 1.99) | 1.20 (0.76, 1.91) | 0.95 (0.59, 1.53) |
HR=hazard ratio; CI = confidence interval;
p-value < 0.05;
p-value < 0.01.
All-cause mortality was assessed through 27 September 2013 and cardiovascular disease related mortality was assessed through 31 December 2009.
Model 1 adjusted for age, sex, smoking status, BMI, hypertension, diabetes, self-reported health status, cognitive status, walking disability, number of medications, and serum total cholesterol. For cardiovascular disease related mortality analyses, it further adjusted for self-reported history of angina or cardiovascular disease.
Model 2 adjusted for all variables in model 1 and microalbuminuria and chronic kidney disease.
Model 3 adjusted for all variables in model 2 and total brain tissue volume (corrected for intracranial volume), cerebral microbleeds, and brain infarcts.
Model 4 adjusted for all variables in model 3 and clinical stroke.